Medicine Stock Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medicine stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medicine Stock Down Today - Breaking & Trending Today

Insider Selling: Editas Medicine, Inc. (NASDAQ:EDIT) CEO Sells 12,191 Shares of Stock

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) CEO Gilmore Neil O’neill sold 12,191 shares of the company’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $5.50, for a total value of $67,050.50. Following the sale, the chief executive officer now owns 315,279 shares of the […] ....

Gilmore Neil Oneill , Entrypoint Capital , Headlands Technologies , Jpmorgan Chase Co , Russell Investments Group Ltd , Editas Medicine Inc , Editas Medicine , Get Free Report , Neilo Neill , Medicine Stock Down , Street Markets , Investments Group , Leber Congenital Amaurosis , Editas Medicine Daily ,

Disc Medicine (NASDAQ:IRON) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report released on Tuesday morning, Benzinga reports. The firm currently has a $85.00 price objective on the stock. Several other equities research analysts also recently commented on the company. Morgan Stanley reduced their target price on Disc […] ....

United States , Raymond James , Stifel Nicolaus , William Richard White , Charles Schwab Investment Management Inc , Morgan Stanley , Disc Medicine Company Profile , York Mellon Corp , Barclays Plc , Disc Medicine Inc , Cantor Fitzgerald , Swiss National Bank , Victory Capital Management Inc , Disc Medicine , Free Report , Moderate Buy , Medicine Stock Down , Get Free Report , Director William Richard White , New York Mellon Corp , Capital Management , National Bank , Charles Schwab Investment Management , Schwab Investment Management , Disc Medicine Daily ,

Editas Medicine (NASDAQ:EDIT) Cut to Sell at StockNews.com

Editas Medicine (NASDAQ:EDIT) Cut to Sell at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los Angeles , United States , Gilmore Neil Oneill , Baisong Mei , International Assets Investment Management , Vanguard Group Inc , Dimensional Fund Advisors , Morgan Stanley , Editas Medicine Inc , Jpmorgan Chase Co , Charles Schwab Investment Management Inc , Los Angeles Capital Management , Editas Medicine , Free Report , Medicine Stock Down , Get Free Report , Neilo Neill , Fund Advisors , Assets Investment Management , Schwab Investment Management , Leber Congenital Amaurosis , Editas Medicine Daily ,

Citigroup Lowers Editas Medicine (NASDAQ:EDIT) Price Target to $15.00

Citigroup Lowers Editas Medicine (NASDAQ:EDIT) Price Target to $15.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Baisong Mei , Gilmore Neil Oneill , Editas Medicine Company Profile , Dimensional Fund Advisors , Vanguard Group Inc , Charles Schwab Investment Management Inc , York Mellon Corp , Morgan Stanley , Jpmorgan Chase Co , Editas Medicine Inc , Mirae Asset Global Investments Co , Editas Medicine , Free Report , Medicine Stock Down , Get Free Report , Neilo Neill , Fund Advisors , Schwab Investment Management , Asset Global Investments , New York Mellon Corp , Leber Congenital Amaurosis , Editas Medicine Daily ,

Prime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Analysts

Prime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel Nicolaus , Robert Nelsen , Sg Americas Securities , Oppenheimer Co , Chelsea Counsel Co , Mirae Asset Global Investments Co , Medicine Inc , Medicine Company Profile , Green Alpha Advisors , Prime Medicine , Get Free Report , Medicine Stock Down , Director Robert Nelsen , Asset Global Investments , Alpha Advisors , Get Free , Prime Editors , Prime Editor , Prime Medicine Daily ,